A phase 1 trial of AP30663, a K Ca 2 channel inhibitor in development for conversion of atrial fibrillation
Yfanti, Christina, Vestbjerg, Birgitte, Van't Westende, Juliette, Edvardsson, Nils, Monfort, Laia Meseguer, Olesen, Morten Salling, Bentzen, Bo Hjorth, Grunnet, Morten, Eveleens Maarse, Boukje C, Diness, Jonas Goldin, Kemme, Michiel J B, Sørensen, Ulrik, Moerland, Matthijs, van Esdonk, Michiel J, Klaassen, Erica S, Gal, Pim, Holst, Anders G
Published in British journal of clinical pharmacology (01.04.2024)
Published in British journal of clinical pharmacology (01.04.2024)
Get full text
Journal Article
A phase 1 trial of AP30663, a KCa2 channel inhibitor in development for conversion of atrial fibrillation
Yfanti, Christina, Vestbjerg, Birgitte, Van't Westende, Juliette, Edvardsson, Nils, Monfort, Laia Meseguer, Olesen, Morten Salling, Bentzen, Bo Hjorth, Grunnet, Morten, Eveleens Maarse, Boukje C, Diness, Jonas Goldin, Kemme, Michiel J B, Sørensen, Ulrik, Moerland, Matthijs, van Esdonk, Michiel J, Klaassen, Erica S, Gal, Pim, Holst, Anders G
Published in British journal of clinical pharmacology (01.04.2024)
Published in British journal of clinical pharmacology (01.04.2024)
Get full text
Journal Article